{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:10:41Z","timestamp":1789452641467,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,10]]},"DOI":"10.7759\/cureus.34850","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T07:13:52Z","timestamp":1676099632000},"source":"Crossref","is-referenced-by-count":7,"title":["Conservative Otosclerosis Treatment With Sodium Fluoride and Other Modern Formulations: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Panagiotis  P","family":"Gogoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nikolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electra K","family":"Sevastatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Korres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Delides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711740110","article-title":"Pathology of the ear","author":"Friedmann I","year":"1994","unstructured":"Friedmann I, Arnold W. Pathology of the ear. Churchill Livingstone, Edinburgh, Scotland; 1994. 174:63-63. 10.1002\/path.1711740110"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02045.x","article-title":"Otosclerosis 1: the aetiopathogenesis of otosclerosis","volume":"63","author":"Uppal S","year":"2009","unstructured":"Uppal S, Bajaj Y, Rustom I, Coatesworth AP. Otosclerosis 1: the aetiopathogenesis of otosclerosis. Int J Clin Pract. 2009, 63:1526-30. 10.1111\/j.1742-1241.2009.02045.x","journal-title":"Int J Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-008-0790-x","article-title":"An overview of the etiology of otosclerosis","volume":"266","author":"Markou K","year":"2009","unstructured":"Markou K, Goudakos J. An overview of the etiology of otosclerosis. Eur Arch Otorhinolaryngol. 2009, 266:25-35. 10.1007\/s00405-008-0790-x","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.mao.0000187050.04286.80","article-title":"Adam Politzer (1835-1920) and the description of otosclerosis","volume":"27","author":"Mudry A","year":"2006","unstructured":"Mudry A. Adam Politzer (1835-1920) and the description of otosclerosis. Otol Neurotol. 2006, 27:276-81. 10.1097\/01.mao.0000187050.04286.80","journal-title":"Otol Neurotol"},{"key":"ref5","article-title":"Total bony occlusion of both labyrinthine and labyrinthitis serosa as a result of progressive spongiosis (Article in German)","author":"Siebenmann F","year":"1912","unstructured":"Siebenmann F. Total bony occlusion of both labyrinthine and labyrinthitis serosa as a result of progressive spongiosis (Article in German). Verhanlungen Dtsch Otol Gesellschaft. 1912, 267-83.","journal-title":"Verhanlungen Dtsch Otol Gesellschaft"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2017.11.003","article-title":"History of otosclerosis and stapes surgery","volume":"51","author":"Nazarian R","year":"2018","unstructured":"Nazarian R, McElveen JT Jr, Eshraghi AA. History of otosclerosis and stapes surgery. Otolaryngol Clin North Am. 2018, 51:275-90. 10.1016\/j.otc.2017.11.003","journal-title":"Otolaryngol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-010-1292-1","article-title":"Etiopathogenesis of otosclerosis","volume":"267","author":"Karosi T","year":"2010","unstructured":"Karosi T, Sziklai I. Etiopathogenesis of otosclerosis. Eur Arch Otorhinolaryngol. 2010, 267:1337-49. 10.1007\/s00405-010-1292-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215114001443","article-title":"Otosclerosis diagnosis, evaluation, pathology, surgical techniques, and outcomes","author":"de Souza C","year":"2014","unstructured":"de Souza C, Goycoolea MV, Sperling NM. Otosclerosis diagnosis, evaluation, pathology, surgical techniques, and outcomes. Plural Publishing, Inc., San Diego, CA; 2014. 10.1017\/S0022215114001443"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-008-0470-3","article-title":"A new locus for otosclerosis, OTSC8, maps to the pericentromeric region of chromosome 9","volume":"123","author":"Bel Hadj Ali I","year":"2008","unstructured":"Bel Hadj Ali I, Thys M, Beltaief N, et al.. A new locus for otosclerosis, OTSC8, maps to the pericentromeric region of chromosome 9. Hum Genet. 2008, 123:267-72. 10.1007\/s00439-008-0470-3","journal-title":"Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20934","article-title":"The etiology of otosclerosis: a combination of genes and environment","volume":"120","author":"Schrauwen I","year":"2010","unstructured":"Schrauwen I, Van Camp G. The etiology of otosclerosis: a combination of genes and environment. Laryngoscope. 2010, 120:1195-202. 10.1002\/lary.20934","journal-title":"Laryngoscope"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1201\/9780203731017","article-title":"Scott-Brown\u2019s otorhinolaryngology and head and neck surgery","author":"Watkinson J","year":"2018","unstructured":"Watkinson J, Clarke R. Scott-Brown\u2019s otorhinolaryngology and head and neck surgery. Volume 2: Paediatrics, the ear, and skull base surgery (8th ed.). CRC Press, Boca Raton, FL; 2018. 1526. 10.1201\/9780203731017"},{"key":"ref12","article-title":"Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology with mild osteogenesis imperfecta","volume":"19","author":"McKenna MJ","year":"1998","unstructured":"McKenna MJ, Kristiansen AG, Bartley ML, Rogus JJ, Haines JL. Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology with mild osteogenesis imperfecta. Am J Otol. 1998, 19:604-10.","journal-title":"Am J Otol"},{"key":"ref13","article-title":"Ultrastructural and immunohistochemical evidence of measles virus in active otosclerosis","volume":"470","author":"McKenna MJ","year":"1990","unstructured":"McKenna MJ, Mills BG. Ultrastructural and immunohistochemical evidence of measles virus in active otosclerosis. Acta Otolaryngol Suppl. 1990, 470:130-9.","journal-title":"Acta Otolaryngol Suppl"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000098664","article-title":"Evidence of increased average age of patients with otosclerosis","volume":"65","author":"Niedermeyer HP","year":"2007","unstructured":"Niedermeyer HP, H\u00e4usler R, Schwub D, Neuner NT, Busch R, Arnold W. Evidence of increased average age of patients with otosclerosis. Adv Otorhinolaryngol. 2007, 65:17-24. 10.1159\/000098664","journal-title":"Adv Otorhinolaryngol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1126\/science.7112122","article-title":"Type II collagen autoimmunity in otosclerosis and Meniere's disease","volume":"217","author":"Yoo TJ","year":"1982","unstructured":"Yoo TJ, Stuart JM, Kang AH, Townes AS, Tomoda K, Dixit S. Type II collagen autoimmunity in otosclerosis and Meniere's disease. Science. 1982, 217:1153-5. 10.1126\/science.7112122","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.1289","article-title":"TGF-beta, BMPS, and their signal transducing mediators, Smads, in rat fracture healing","volume":"60","author":"Yu Y","year":"2002","unstructured":"Yu Y, Yang JL, Chapman-Sheath PJ, Walsh WR. TGF-beta, BMPS, and their signal transducing mediators, Smads, in rat fracture healing. J Biomed Mater Res. 2002, 60:392-7. 10.1002\/jbm.1289","journal-title":"J Biomed Mater Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/mao.0b013e318164d12c","article-title":"Relation between renin-angiotensin-aldosterone system and otosclerosis: a genetic association and in vitro study","volume":"29","author":"Imauchi Y","year":"2008","unstructured":"Imauchi Y, Jeunema\u00eetre X, Boussion M, Ferrary E, Sterkers O, Grayeli AB. Relation between renin-angiotensin-aldosterone system and otosclerosis: a genetic association and in vitro study. Otol Neurotol. 2008, 29:295-301. 10.1097\/mao.0b013e318164d12c","journal-title":"Otol Neurotol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.2003.00675.x","article-title":"The aetiology of otosclerosis: a review of the literature","volume":"28","author":"Menger DJ","year":"2003","unstructured":"Menger DJ, Tange RA. The aetiology of otosclerosis: a review of the literature. Clin Otolaryngol Allied Sci. 2003, 28:112-20. 10.1046\/j.1365-2273.2003.00675.x","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"ref19","article-title":"Myths in neurotology","volume":"13","author":"Schuknecht HF","year":"1992","unstructured":"Schuknecht HF. Myths in neurotology. Am J Otol. 1992, 13:124-6.","journal-title":"Am J Otol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1017\/S002221511200103X","article-title":"","author":"Lalwani AK","year":"2007","unstructured":"Lalwani AK. Current diagnosis and treatment in otolaryngology-head and neck surgery: second edition. McGraw-Hill Medical, New York, NY; 2007. 10.1017\/S002221511200103X"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3109\/05384916409074070","article-title":"Paracusis willisii","volume":"3","author":"Dudok de Wit CA","year":"1964","unstructured":"Dudok de Wit CA, van Dishoeck HA. Paracusis willisii. Int Audiol. 1964, 3:43-53. 10.3109\/05384916409074070","journal-title":"Int Audiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5152\/iao.2019.5512","article-title":"Prevalence and severity of tinnitus in otosclerosis: preliminary findings from validated questionnaires","volume":"15","author":"Skarzynski PH","year":"2019","unstructured":"Skarzynski PH, Dziendziel B, Gos E, Wlodarczyk E, Miaskiewicz B, Rajchel JJ, Skarzynski H. Prevalence and severity of tinnitus in otosclerosis: preliminary findings from validated questionnaires. J Int Adv Otol. 2019, 15:277-82. 10.5152\/iao.2019.5512","journal-title":"J Int Adv Otol"},{"key":"ref23","article-title":"Tinnitus and otosclerosis","volume":"5","author":"Deggouj N","year":"2009","unstructured":"Deggouj N, Castelein S, Gerard JM, Decat M, Gersdorff M. Tinnitus and otosclerosis. B-ENT. 2009, 5:241-4.","journal-title":"B-ENT"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.03.009","article-title":"Otosclerosis: an autoimmune disease?","volume":"9","author":"Karosi T","year":"2009","unstructured":"Karosi T, Szekanecz Z, Sziklai I. Otosclerosis: an autoimmune disease?. Autoimmun Rev. 2009, 9:95-101. 10.1016\/j.autrev.2009.03.009","journal-title":"Autoimmun Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02046.x","article-title":"Otosclerosis 2: the medical management of otosclerosis","volume":"64","author":"Uppal S","year":"2010","unstructured":"Uppal S, Bajaj Y, Coatesworth AP. Otosclerosis 2: the medical management of otosclerosis. Int J Clin Pract. 2010, 64:256-65. 10.1111\/j.1742-1241.2009.02046.x","journal-title":"Int J Clin Pract"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-012-2126-0","article-title":"Perspectives of pharmacological treatment in otosclerosis","volume":"270","author":"Liktor B","year":"2013","unstructured":"Liktor B, Szekanecz Z, Batta TJ, Sziklai I, Karosi T. Perspectives of pharmacological treatment in otosclerosis. Eur Arch Otorhinolaryngol. 2013, 270:793-804. 10.1007\/s00405-012-2126-0","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi H","year":"2007","unstructured":"Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007, 7:292-304. 10.1038\/nri2062","journal-title":"Nat Rev Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum SL","year":"2000","unstructured":"Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000, 289:1504-8. 10.1126\/science.289.5484.1504","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000150702.28451.35","article-title":"Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule","volume":"115","author":"Zehnder AF","year":"2005","unstructured":"Zehnder AF, Kristiansen AG, Adams JC, Merchant SN, McKenna MJ. Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule. Laryngoscope. 2005, 115:172-7. 10.1097\/01.mlg.0000150702.28451.35","journal-title":"Laryngoscope"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000225928.35838.e5","article-title":"Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic Stapes footplates in connection with measles virus positivity","volume":"116","author":"Karosi T","year":"2006","unstructured":"Karosi T, J\u00f3kay I, K\u00f3nya J, et al.. Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic Stapes footplates in connection with measles virus positivity. Laryngoscope. 2006, 116:1427-33. 10.1097\/01.mlg.0000225928.35838.e5","journal-title":"Laryngoscope"},{"key":"ref31","article-title":"Medical treatment of otosclerosis: rationale for use of bisphosphonates","volume":"14","author":"Brookler K","year":"2008","unstructured":"Brookler K. Medical treatment of otosclerosis: rationale for use of bisphosphonates. Int Tinnitus J. 2008, 14:92-6.","journal-title":"Int Tinnitus J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/01.mao.0000169304.72519.d2","article-title":"Histologic otosclerosis is associated with the presence of measles virus in the stapes footplate","volume":"26","author":"Karosi T","year":"2005","unstructured":"Karosi T, K\u00f3nya J, Petk\u00f3 M, Sziklai I. Histologic otosclerosis is associated with the presence of measles virus in the stapes footplate. Otol Neurotol. 2005, 26:1128-33. 10.1097\/01.mao.0000169304.72519.d2","journal-title":"Otol Neurotol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/01.MLG.0000165462.35495.DF","article-title":"Codetection of measles virus and tumor necrosis factor-alpha mRNA in otosclerotic stapes footplates","volume":"115","author":"Karosi T","year":"2005","unstructured":"Karosi T, K\u00f3nya J, Szab\u00f3 LZ, Pytel J, J\u00f3ri J, Szalm\u00e1s A, Sziklai I. Codetection of measles virus and tumor necrosis factor-alpha mRNA in otosclerotic stapes footplates. Laryngoscope. 2005, 115:1291-7. 10.1097\/01.MLG.0000165462.35495.DF","journal-title":"Laryngoscope"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-009-0967-y","article-title":"Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss","volume":"266","author":"Sziklai I","year":"2009","unstructured":"Sziklai I, Batta TJ, Karosi T. Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2009, 266:1711-8. 10.1007\/s00405-009-0967-y","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-010-1404-y","article-title":"Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity","volume":"268","author":"Karosi T","year":"2011","unstructured":"Karosi T, Csomor P, Szalm\u00e1s A, K\u00f3nya J, Petk\u00f3 M, Sziklai I. Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity. Eur Arch Otorhinolaryngol. 2011, 268:357-65. 10.1007\/s00405-010-1404-y","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2006.67.9.21999","article-title":"Otosclerosis: a review of aetiology, management and outcomes","volume":"67","author":"Siddiq MA","year":"2006","unstructured":"Siddiq MA. Otosclerosis: a review of aetiology, management and outcomes. Br J Hosp Med (Lond). 2006, 67:470, 472-6. 10.12968\/hmed.2006.67.9.21999","journal-title":"Br J Hosp Med (Lond)"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1016\/S0030-6665(20)30823-9","article-title":"Hearing aids and otosclerosis","volume":"26","author":"Johnson EW","year":"1993","unstructured":"Johnson EW. Hearing aids and otosclerosis. Otolaryngol Clin North Am. 1993, 26:491-502.","journal-title":"Otolaryngol Clin North Am"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e31802dfc59","article-title":"New perspectives for middle ear implants: first results in otosclerosis with mixed hearing loss","volume":"117","author":"Venail F","year":"2007","unstructured":"Venail F, Lavieille JP, Meller R, Deveze A, Tardivet L, Magnan J. New perspectives for middle ear implants: first results in otosclerosis with mixed hearing loss. Laryngoscope. 2007, 117:552-5. 10.1097\/MLG.0b013e31802dfc59","journal-title":"Laryngoscope"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-6657(11)70670-9","article-title":"Current aspects of etiology, diagnosis and therapy of otosclerosis","volume":"65","author":"Thomas JP","year":"2011","unstructured":"Thomas JP, Minovi A, Dazert S. Current aspects of etiology, diagnosis and therapy of otosclerosis. Otolaryngol Pol. 2011, 65:162-70. 10.1016\/S0030-6657(11)70670-9","journal-title":"Otolaryngol Pol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/01.JAA.0000511784.21936.1b","article-title":"Otosclerosis: an update on diagnosis and treatment","volume":"30","author":"Batson L","year":"2017","unstructured":"Batson L, Rizzolo D. Otosclerosis: an update on diagnosis and treatment. JAAPA. 2017, 30:17-22. 10.1097\/01.JAA.0000511784.21936.1b","journal-title":"JAAPA"},{"key":"ref41","article-title":"Otospongiosis and sodium fluoride. A clinical double-blind, placebo-controlled study on sodium fluoride treatment in otospongiosis","volume":"10","author":"Bretlau P","year":"1989","unstructured":"Bretlau P, Salomon G, Johnsen NJ. Otospongiosis and sodium fluoride. A clinical double-blind, placebo-controlled study on sodium fluoride treatment in otospongiosis. Am J Otol. 1989, 10:20-2.","journal-title":"Am J Otol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1590\/S1808-86942012000200012","article-title":"The effectiveness of audiometric evaluation in drug treatment for otospongiosis","volume":"78","author":"Vicente Ade O","year":"2012","unstructured":"Vicente Ade O, Yamashita HK, Cruz OL, Suzuki FB, Penido Nde O. The effectiveness of audiometric evaluation in drug treatment for otospongiosis. Braz J Otorhinolaryngol. 2012, 78:73-9. 10.1590\/S1808-86942012000200012","journal-title":"Braz J Otorhinolaryngol"},{"key":"ref43","article-title":"Mixed hearing loss in otosclerosis: indication for long-term follow-up","volume":"15","author":"Ramsay HA","year":"1994","unstructured":"Ramsay HA, Linthicum FH Jr. Mixed hearing loss in otosclerosis: indication for long-term follow-up. Am J Otol. 1994, 15:536-9.","journal-title":"Am J Otol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1177\/000348940911801206","article-title":"Surgical and medical treatment of hearing loss in mixed otosclerosis","volume":"118","author":"F\u00e9lix-Trujillo MM","year":"2009","unstructured":"F\u00e9lix-Trujillo MM, Valdez-Mart\u00ednez E, Ram\u00edrez JE, Lozano-Morales R. Surgical and medical treatment of hearing loss in mixed otosclerosis. Ann Otol Rhinol Laryngol. 2009, 118:859-65. 10.1177\/000348940911801206","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1177\/000348947408300510","article-title":"Ten years experience with fluoride in otosclerotic (otospongiotic) patients","volume":"83","author":"Shambaugh GE Jr","year":"1974","unstructured":"Shambaugh GE Jr, Causse J. Ten years experience with fluoride in otosclerotic (otospongiotic) patients. Ann Otol Rhinol Laryngol. 1974, 83:635-42. 10.1177\/000348947408300510","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/000164801300043361","article-title":"Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation","volume":"121","author":"Derks W","year":"2001","unstructured":"Derks W, De Groot JA, Raymakers JA, Veldman JE. Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation. Acta Otolaryngol. 2001, 121:174-7. 10.1080\/000164801300043361","journal-title":"Acta Otolaryngol"},{"key":"ref47","article-title":"Sodium fluoride: effectiveness of treatment for cochlear otosclerosis","volume":"7","author":"Forquer BD","year":"1986","unstructured":"Forquer BD, Linthicum FH, Bennett C. Sodium fluoride: effectiveness of treatment for cochlear otosclerosis. Am J Otol. 1986, 7:121-5.","journal-title":"Am J Otol"},{"key":"ref48","article-title":"[Sodium fluoride and otospongiosis] (Article in French)","volume":"98","author":"B\u00e9b\u00e9ar JP","year":"1977","unstructured":"B\u00e9b\u00e9ar JP, H\u00e9dreville R. [Sodium fluoride and otospongiosis] (Article in French). Rev Laryngol Otol Rhinol (Bord). 1977, 98:221-5.","journal-title":"Rev Laryngol Otol Rhinol (Bord)"},{"key":"ref49","article-title":"Sodium fluoride andotospongiosis (Article in French)","volume":"37","author":"Debry C","year":"1988","unstructured":"Debry C, Bonnat H, Conraux C, Fraysse L. Sodium fluoride andotospongiosis (Article in French). J Fr Otorhinolaryngol. 1988, 37:339-47.","journal-title":"J Fr Otorhinolaryngol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1177\/019459989310900312","article-title":"The effects of etidronate disodium on progressive hearing loss from otosclerosis","volume":"109","author":"Kennedy DW","year":"1993","unstructured":"Kennedy DW, Hoffer ME, Holliday M. The effects of etidronate disodium on progressive hearing loss from otosclerosis. Otolaryngol Head Neck Surg. 1993, 109:461-7. 10.1177\/019459989310900312","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1177\/014556139707600605","article-title":"Etidronate for the the neurotologic symptoms of otosclerosis: preliminary study","volume":"76","author":"Brookler KH","year":"1997","unstructured":"Brookler KH, Tanyeri H. Etidronate for the the neurotologic symptoms of otosclerosis: preliminary study. Ear Nose Throat J. 1997, 76:371-81.","journal-title":"Ear Nose Throat J"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.91","article-title":"Third-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up","volume":"2","author":"Jan TA","year":"2017","unstructured":"Jan TA, Remenschneider AK, Halpin C, Seton M, McKenna MJ, Quesnel AM. Third-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up. Laryngoscope Investig Otolaryngol. 2017, 2:262-8. 10.1002\/lio2.91","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-199309000-00013","article-title":"Sodium fluoride therapy","volume":"14","author":"Causse JR","year":"1993","unstructured":"Causse JR, Causse JB, Uriel J, Berges J, Shambaugh GE Jr, Bretlau P. Sodium fluoride therapy. Am J Otol. 1993, 14:482-90. 10.1097\/00129492-199309000-00013","journal-title":"Am J Otol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1177\/000348947808700605","article-title":"Otosclerosis: vestibular symptoms and sensorineural hearing loss","volume":"87","author":"Cody DT","year":"1978","unstructured":"Cody DT, Baker HL Jr. Otosclerosis: vestibular symptoms and sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1978, 87:778-96. 10.1177\/000348947808700605","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2017.11.006","article-title":"Medical management of otosclerosis","volume":"51","author":"de Oliveira Penido N","year":"2018","unstructured":"de Oliveira Penido N, de Oliveira Vicente A. Medical management of otosclerosis. Otolaryngol Clin North Am. 2018, 51:441-52. 10.1016\/j.otc.2017.11.006","journal-title":"Otolaryngol Clin North Am"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)60752-0","article-title":"Adverse effects of bisphosphonates: implications for osteoporosis management","volume":"84","author":"Kennel KA","year":"2009","unstructured":"Kennel KA, Drake MT. Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc. 2009, 84:632-7. 10.1016\/S0025-6196(11)60752-0","journal-title":"Mayo Clin Proc"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.2165\/00024669-200403060-00004","article-title":"The role of bisphosphonates in the treatment of skeletal complications of breast cancer","volume":"3","author":"El-Rayes BF","year":"2004","unstructured":"El-Rayes BF, LoRusso PM. The role of bisphosphonates in the treatment of skeletal complications of breast cancer. Am J Cancer. 2004, 3:369-75. 10.2165\/00024669-200403060-00004","journal-title":"Am J Cancer"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200727060-00005","article-title":"Clodronic acid in the treatment of postmenopausal osteoporosis","volume":"27","author":"Tanakol R","year":"2007","unstructured":"Tanakol R, Yarman S, Bayraktaroglu T, Boztepe H, Alag\u00f6l F. Clodronic acid in the treatment of postmenopausal osteoporosis. Clin Drug Investig. 2007, 27:419-33. 10.2165\/00044011-200727060-00005","journal-title":"Clin Drug Investig"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e318268d1b3","article-title":"Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis","volume":"33","author":"Quesnel AM","year":"2012","unstructured":"Quesnel AM, Seton M, Merchant SN, Halpin C, McKenna MJ. Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis. Otol Neurotol. 2012, 33:1308-14. 10.1097\/MAO.0b013e318268d1b3","journal-title":"Otol Neurotol"},{"key":"ref60","article-title":"Double-blind study on the effectiveness of a bioflavonoid in the control of tinnitus in otosclerosis","volume":"33","author":"Sziklai I","year":"1992","unstructured":"Sziklai I, Komora V, Rib\u00e1ri O. Double-blind study on the effectiveness of a bioflavonoid in the control of tinnitus in otosclerosis. Acta Chir Hung. 1992, 33:101-7.","journal-title":"Acta Chir Hung"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1398.044","article-title":"Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases","volume":"1109","author":"Orbach H","year":"2007","unstructured":"Orbach H, Zandman-Goddard G, Amital H, et al.. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci. 2007, 1109:385-400. 10.1196\/annals.1398.044","journal-title":"Ann N Y Acad Sci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1177\/019459988509300305","article-title":"Vitamin D deficiency and otosclerosis","volume":"93","author":"Brookes GB","year":"1985","unstructured":"Brookes GB. Vitamin D deficiency and otosclerosis. Otolaryngol Head Neck Surg. 1985, 93:313-21. 10.1177\/019459988509300305","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.4158\/EP10281.RA","article-title":"Medications that affect calcium","volume":"17","author":"Ruppe MD","year":"2011","unstructured":"Ruppe MD. Medications that affect calcium. Endocr Pract. 2011, 17:26-30. 10.4158\/EP10281.RA","journal-title":"Endocr Pract"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013305","article-title":"Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK","volume":"5","author":"Hu L","year":"2010","unstructured":"Hu L, Lind T, Sundqvist A, Jacobson A, Melhus H. Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK. PLoS One. 2010, 5:e13305. 10.1371\/journal.pone.0013305","journal-title":"PLoS One"},{"key":"ref65","article-title":"Perioperative glucocorticoid treatment does not influence early post-laser stapedotomy hearing thresholds","volume":"21","author":"Riechelmann H","year":"2000","unstructured":"Riechelmann H, Tholen M, Keck T, Rettinger G. Perioperative glucocorticoid treatment does not influence early post-laser stapedotomy hearing thresholds. Am J Otol. 2000, 21:809-12.","journal-title":"Am J Otol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1159\/000073516","article-title":"Cortisol levels in the human perilymph after intravenous administration of prednisolone","volume":"8","author":"Niedermeyer HP","year":"2003","unstructured":"Niedermeyer HP, Zahneisen G, Luppa P, Busch R, Arnold W. Cortisol levels in the human perilymph after intravenous administration of prednisolone. Audiol Neurootol. 2003, 8:316-21. 10.1159\/000073516","journal-title":"Audiol Neurootol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2004.11.001","article-title":"Intratympanic dexamethasone injection effects on transient-evoked otoacoustic emission","volume":"26","author":"Yilmaz I","year":"2005","unstructured":"Yilmaz I, Yilmazer C, Erkan AN, Aslan SG, Ozluoglu LN. Intratympanic dexamethasone injection effects on transient-evoked otoacoustic emission. Am J Otolaryngol. 2005, 26:113-7. 10.1016\/j.amjoto.2004.11.001","journal-title":"Am J Otolaryngol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024285","article-title":"Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-\u03baB inhibitors in ovarian cancer therapy","volume":"6","author":"Zerbini LF","year":"2011","unstructured":"Zerbini LF, Tamura RE, Correa RG, et al.. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-\u03baB inhibitors in ovarian cancer therapy. PLoS One. 2011, 6:e24285. 10.1371\/journal.pone.0024285","journal-title":"PLoS One"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1113\/eph8602135","article-title":"Impact of the timing of indomethacin treatment in a model of synchronized bone remodelling in rats","volume":"86","author":"Guez D","year":"2001","unstructured":"Guez D, Lesclous P, Baroukh B, Saffar JL. Impact of the timing of indomethacin treatment in a model of synchronized bone remodelling in rats. Exp Physiol. 2001, 86:373-9. 10.1113\/eph8602135","journal-title":"Exp Physiol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996822","article-title":"[Clinical aspects of the osteolytic (inflammatory) phase of cochlear otosclerosis]","volume":"78","author":"Arnold W","year":"1999","unstructured":"Arnold W, Kau R, Schwaiger M. [Clinical aspects of the osteolytic (inflammatory) phase of cochlear otosclerosis]. Laryngorhinootologie. 1999, 78:20-3. 10.1055\/s-2007-996822","journal-title":"Laryngorhinootologie"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1159\/000095897","article-title":"Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss","volume":"11","author":"Van Wijk F","year":"2006","unstructured":"Van Wijk F, Staecker H, Keithley E, Lefebvre PP. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol Neurootol. 2006, 11:357-65. 10.1159\/000095897","journal-title":"Audiol Neurootol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1080\/00498250802590745","article-title":"Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats","volume":"39","author":"Miyaji Y","year":"2009","unstructured":"Miyaji Y, Kurihara A, Kamiyama E, Shiiki T, Kawai K, Okazaki O. Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats. Xenobiotica. 2009, 39:113-24. 10.1080\/00498250802590745","journal-title":"Xenobiotica"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32832ca41c","article-title":"Denosumab update","volume":"21","author":"Lewiecki EM","year":"2009","unstructured":"Lewiecki EM. Denosumab update. Curr Opin Rheumatol. 2009, 21:369-73. 10.1097\/BOR.0b013e32832ca41c","journal-title":"Curr Opin Rheumatol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-007-0253-9","article-title":"The influence of measles vaccination on the incidence of otosclerosis in Germany","volume":"264","author":"Arnold W","year":"2007","unstructured":"Arnold W, Busch R, Arnold A, Ritscher B, Neiss A, Niedermeyer HP. The influence of measles vaccination on the incidence of otosclerosis in Germany. Eur Arch Otorhinolaryngol. 2007, 264:741-8. 10.1007\/s00405-007-0253-9","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13909","article-title":"Role of the endoscope in cochlear implantation: a systematic review","volume":"47","author":"Poutoglidis A","year":"2022","unstructured":"Poutoglidis A, Fyrmpas G, Vlachtsis K, et al.. Role of the endoscope in cochlear implantation: a systematic review. Clin Otolaryngol. 2022, 47:708-16. 10.1111\/coa.13909","journal-title":"Clin Otolaryngol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14126","article-title":"Conventional microscopic stapedotomy: an obsolete technique or still the gold standard for the management of otosclerosis?","volume":"13","author":"Poutoglidis A","year":"2021","unstructured":"Poutoglidis A, Tsetsos N, Vardaxi C, Fyrmpas G, Poutoglidou F, Kilmpasanis A, Vlachtsis K. Conventional microscopic stapedotomy: an obsolete technique or still the gold standard for the management of otosclerosis?. Cureus. 2021, 13:e14126. 10.7759\/cureus.14126","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/135852-conservative-otosclerosis-treatment-with-sodium-fluoride-and-other-modern-formulations-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:59Z","timestamp":1707508739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/135852-conservative-otosclerosis-treatment-with-sodium-fluoride-and-other-modern-formulations-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":76,"URL":"https:\/\/doi.org\/10.7759\/cureus.34850","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,10]]}}}